MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer (MITO-5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00401674
Recruitment Status : Completed
First Posted : November 20, 2006
Last Update Posted : January 14, 2016
Information provided by (Responsible Party):
National Cancer Institute, Naples